Gates Foundation Funding $40 Million Effort to Help Develop MRNA Vaccines in Africa in Coming Years

Australia News News

Gates Foundation Funding $40 Million Effort to Help Develop MRNA Vaccines in Africa in Coming Years
Australia Latest News,Australia Headlines
  • 📰 NEWSMAX
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 71%

A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID19 pandemic, the Bill & Melinda Gates Foundation announced Monday.While it could still take at...

DAKAR, Senegal — A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill & Melinda Gates Foundation announced Monday.

The announcement comes as the foundation opens its annual three-day Grand Challenges event, which brings together scientists and public health researchers from around the world. Those COVID-19 mRNA vaccines were fast-tracked through the regulatory process and granted emergency use authorization. The new vaccines under development in Africa face a far longer development timeline — anywhere from three to seven years.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NEWSMAX /  🏆 16. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsGates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsThe Bill & Melinda Gates Foundation is announcing $40 million in funding to help develop messenger RNA vaccines in Africa. The new investment will provide the technology to two Africa-based vaccine producers — Institut Pasteur in Senegal and Biovac in South Africa. Among the diseases they hope to target are Rift Valley fever and tuberculosis. The COVID-19 mRNA vaccines were fast-tracked through the regulatory process and granted emergency use authorization. The new vaccines under development in
Read more »

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsGates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsThe Bill & Melinda Gates Foundation is announcing $40 million in funding to help develop messenger RNA vaccines in Africa
Read more »

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsGates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsThe Bill & Melinda Gates Foundation is announcing $40 million in funding to help develop messenger RNA vaccines in Africa.
Read more »

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsGates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming yearsThe Bill & Melinda Gates Foundation is announcing $40 million in funding to help develop messenger RNA vaccines in Africa.
Read more »

Gates Foundation Funds $40 Million for mRNA Vaccines in AfricaA $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill & Melinda Gates Foundation announced Monday.
Read more »

Mark Cuban loved this ‘Shark Tank' company's mission—but the CEO made a $40 million mistake: ‘You blew it'Mark Cuban loved this ‘Shark Tank' company's mission—but the CEO made a $40 million mistake: ‘You blew it'A strong mission doesn’t guarantee your startup an investment. Return Home CEO Micah Truman learned that lesson on Friday’s episode of ABC’s…
Read more »



Render Time: 2025-02-27 12:05:01